MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

BMS-582949 hydrochloride

CAS No. : 912806-16-7

MCE 站：BMS-582949 hydrochloride

产品活性：BMS-582949 hydrochloride 是具有口服活性的、高度选择性的p38α MAPK 抑制剂，其IC₅₀ 值为13 nM。BMS-582949 hydrochloride 具有明显改善的药代动力学特征，能用于炎症性疾病的研究。

研究领域：MAPK/ERK Pathway  |  Autophagy

作用靶点：p38 MAPK  |  Autophagy

In Vitro: BMS-582949 displays a p38α IC₅₀ of 13 nM ａnd a cellular TNFα IC₅₀ of 50 nM.
BMS-582949 is a weak inhibitor of CYP3A4 BMS-582949 displays >2000-fold selectivity for p38α over a diverse panel of 57 kinases that include serine kinases, nonreceptor tyrosine kinases, receptor tyrosine kinases, ａnd the p38γ ａnd δ isoforms.

In Vivo: BMS-582949 (5-100 mg/kg, orally) is effective in both the acute murine model of inflammation ａnd rat adjuvant arthritis model despite its slightly reduced potency.

相关产品：Drug Repurposing Compound Library Plus  |  Clinical Compound Library Plus  |  Bioactive Compound Library Plus  |  Immunology/Inflammation Compound Library  |  Kinase Inhibitor Library  |  MAPK Compound Library  |  Clinical Compound Library  |  Autophagy Compound Library  |  Drug Repurposing Compound Library  |  Reprogramming Compound Library  |  Oxygen Sensing Compound Library  |  Anti-COVID-19 Compound Library  |  Pyroptosis Compound Library  |  Orally Active Compound Library  |  SB 203580  |  SB 202190  |  Doramapimod  |  Hesperetin  |  PD 169316  |  Neflamapimod  |  TAK-715  |  SB 239063  |  Dehydrocorydaline chloride  |  Talmapimod  |  PF-3644022  |  Bakuchiol  |  MAPK13-IN-1  |  Skatole  |  Semapimod tetrahydrochloride  |  Licochalcone E  |  SD 0006  |  ITX5061  |  p38α inhibitor 1  |  Rhoifolin  |  SKF-86002  |  Dihydrocaffeic acid  |  Nitidine chloride  |  p38 MAPK-IN-1  |  Ferulic acid methyl ester  |  SD-169  |  C16-PAF  |  Paris saponin VII

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。